SPOTLIGHT -
AAO recap: Clinical trial updates, new innovations presented at America's biggest ophthalmic conference
A combination of posters, podium presentations and instructional courses provided invaluable revelations to the ophthalmic community.
No negative effects in DMO patients reported following pandemic-imposed health care restrictions
The data analysis showed that the macular thickness decreased across all time periods and in all macular regions for all terciles.
Disrupting the glaucoma treatment paradigm with novel femtosecond laser from ViaLase
Shawn O'Neil of ViaLase shares updates on the company's femtosecond laser, image-guided, high-precision trabeculotomy (FLigHT) treatment.
Trukera Medical rebranding ushers in new era of expansion into cornea market
Adam Szaronos, President and CEO of Trukera Medical, discusses the recent rebranding of TearLab as well as the launch of the ScoutPro Osmolarity System.
